These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24391229)

  • 1. A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine.
    Ansah C; Mensah KB
    Ghana Med J; 2013 Sep; 47(3):137-47. PubMed ID: 24391229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in naturally derived antimalarials: cryptolepine analogues.
    Wright CW
    J Pharm Pharmacol; 2007 Jun; 59(6):899-904. PubMed ID: 17637183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight.
    Tudu CK; Bandyopadhyay A; Kumar M; Radha ; Das T; Nandy S; Ghorai M; Gopalakrishnan AV; Proćków J; Dey A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):229-238. PubMed ID: 36251044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Chemistry and Pharmacology of Cryptolepine.
    Shnyder SD; Wright CW
    Prog Chem Org Nat Prod; 2021; 115():177-203. PubMed ID: 33797643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory properties of cryptolepine.
    Olajide OA; Ajayi AM; Wright CW
    Phytother Res; 2009 Oct; 23(10):1421-5. PubMed ID: 19288476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine.
    Ansah C; Khan A; Gooderham NJ
    Toxicology; 2005 Mar; 208(1):141-7. PubMed ID: 15664441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta.
    Gibbons S; Fallah F; Wright CW
    Phytother Res; 2003 Apr; 17(4):434-6. PubMed ID: 12722159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine.
    Forkuo AD; Ansah C; Mensah KB; Annan K; Gyan B; Theron A; Mancama D; Wright CW
    Malar J; 2017 Dec; 16(1):496. PubMed ID: 29282057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel indoloquinoline alkaloid glycosides from
    Aggrey MO; Wang WQ; Xuan LJ
    Nat Prod Res; 2024 Aug; 38(16):2756-2762. PubMed ID: 37427973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxic.
    Ansah C; Gooderham NJ
    Toxicol Sci; 2002 Dec; 70(2):245-51. PubMed ID: 12441369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors.
    Rauwald HW; Kober M; Mutschler E; Lambrecht G
    Planta Med; 1992 Dec; 58(6):486-8. PubMed ID: 1484884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
    Dassonneville L; Lansiaux A; Wattelet A; Wattez N; Mahieu C; Van Miert S; Pieters L; Bailly C
    Eur J Pharmacol; 2000 Dec; 409(1):9-18. PubMed ID: 11099695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling.
    Domfeh SA; Narkwa PW; Quaye O; Kusi KA; Awandare GA; Ansah C; Salam A; Mutocheluh M
    BMC Complement Med Ther; 2021 Jun; 21(1):161. PubMed ID: 34078370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoloquinoline Alkaloids as Antimalarials: Advances, Challenges, and Opportunities.
    Parvatkar PT; Diagne K; Zhao Y; Manetsch R
    ChemMedChem; 2024 Sep; 19(18):e202400254. PubMed ID: 38840271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anti-malarial action of cryptolepine and artemisinins.
    Forkuo AD; Ansah C; Boadu KM; Boampong JN; Ameyaw EO; Gyan BA; Arku AT; Ofori MF
    Malar J; 2016 Feb; 15():89. PubMed ID: 26879905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lipopolysaccharide (LPS)-induced neuroinflammatory response by polysaccharide fractions of Khaya grandifoliola (C.D.C.) stem bark, Cryptolepis sanguinolenta (Lindl.) Schltr and Cymbopogon citratus Stapf leaves in raw 264.7 macrophages and U87 glioblastoma cells.
    Mediesse FK; Boudjeko T; Hasitha A; Gangadhar M; Mbacham WF; Yogeeswari P
    BMC Complement Altern Med; 2018 Mar; 18(1):86. PubMed ID: 29530027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Hydroxyneocryptolepine, a new indoloquinoline alkaloid from the roots of
    Aggrey MO; Wang WQ; Xuan LJ
    Nat Prod Res; 2024 Jul; ():1-6. PubMed ID: 39066563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.
    Bailly C; Laine W; Baldeyrou B; De Pauw-Gillet MC; Colson P; Houssier C; Cimanga K; Van Miert S; Vlietinck AJ; Pieters L
    Anticancer Drug Des; 2000 Jun; 15(3):191-201. PubMed ID: 11049087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
    Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
    Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cryptolepine inhibits DNA binding of NF-kappaB.
    Olajide OA; Heiss EH; Schachner D; Wright CW; Vollmar AM; Dirsch VM
    Bioorg Med Chem; 2007 Jan; 15(1):43-9. PubMed ID: 17064915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.